153 related articles for article (PubMed ID: 26058565)
21. Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide.
Gellerman G; Baskin S; Galia L; Gilad Y; Firer MA
Anticancer Drugs; 2013 Feb; 24(2):112-9. PubMed ID: 23187462
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure-activity relationship study of organometallic bioconjugates of the cyclic octapeptide octreotate.
Gross A; Habig D; Metzler-Nolte N
Chembiochem; 2013 Dec; 14(18):2472-9. PubMed ID: 24218362
[TBL] [Abstract][Full Text] [Related]
23. Disulfide-based multifunctional conjugates for targeted theranostic drug delivery.
Lee MH; Sessler JL; Kim JS
Acc Chem Res; 2015 Nov; 48(11):2935-46. PubMed ID: 26513450
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
25. Targeted chemotherapy using a cytotoxic somatostatin conjugate to inhibit tumor growth and metastasis in nude mice.
Sun LC; Mackey LV; Luo J; Fuselier JA; Coy DH
Clin Med Oncol; 2008; 2():491-9. PubMed ID: 21892324
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin analogs - from new molecules to new applications.
Pawlikowski M; Mełeń-Mucha G
Curr Opin Pharmacol; 2004 Dec; 4(6):608-13. PubMed ID: 15525552
[TBL] [Abstract][Full Text] [Related]
27. Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential.
Denora N; Laquintana V; Trapani A; Lopedota A; Latrofa A; Gallo JM; Trapani G
Mol Pharm; 2010 Dec; 7(6):2255-69. PubMed ID: 20958082
[TBL] [Abstract][Full Text] [Related]
28. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
Okarvi SM
Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
[TBL] [Abstract][Full Text] [Related]
29. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
30. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
31. Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
Lindberg J; Nilvebrant J; Nygren PÅ; Lehmann F
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641586
[TBL] [Abstract][Full Text] [Related]
32. Biolabile peptidyl delivery systems toward sequential drug release.
Ragozin E; Redko B; Tuchinsky E; Rozovsky A; Albeck A; Grynszpan F; Gellerman G
Biopolymers; 2016 Jan; 106(1):119-32. PubMed ID: 26662352
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization and in vitro evaluation of a bone targeting delivery system for salmon calcitonin.
Bhandari KH; Newa M; Uludag H; Doschak MR
Int J Pharm; 2010 Jul; 394(1-2):26-34. PubMed ID: 20412845
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.
De K; Bhowmik A; Behera A; Banerjee I; Ghosh MK; Misra M
J Pept Sci; 2012 Dec; 18(12):720-30. PubMed ID: 23109400
[TBL] [Abstract][Full Text] [Related]
35. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
36. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
37. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of intercalating somatostatin receptor binding peptide conjugates for endoradiotherapy.
Graham K; Wang Q; Garcia Boy R; Eisenhut M; Haberkorn U; Mier W
J Pharm Pharm Sci; 2007; 10(2):286s-297s. PubMed ID: 17718932
[TBL] [Abstract][Full Text] [Related]
39. Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents.
Falciani C; Brunetti J; Pagliuca C; Menichetti S; Vitellozzi L; Lelli B; Pini A; Bracci L
ChemMedChem; 2010 Apr; 5(4):567-74. PubMed ID: 20222099
[TBL] [Abstract][Full Text] [Related]
40. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.
Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M
J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
